GlassScriptPhysician profile
Adam Amir
NPI 1407419922
$5,207.05
in general payments reported to CMS, 2019-2025
10 companies · $1,317 in 2025
The $1,317 reported for 2025 was more than what 78% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,603 · 2024: $1,287 · 2025: $1,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,629 · Travel and Lodging: $2,460 · Education: $65.22 · Grant: $52.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,629.14 |
| Travel and Lodging | $2,460.11 |
| Education | $65.22 |
| Grant | $52.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,031.33 | 2023-2025 | Vanta Adaptivestim, Intellis Adaptivestim, Accurian |
| Curonix LLC | $785.12 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $540.06 | 2025 | Proclaim |
| Nevro Corp. | $268.83 | 2023 | Senza |
| Boston Scientific Corporation | $165.28 | 2025 | Intracept |
| Hydrocision, INC. | $150.00 | 2024 | Tenjet |
| Avanos Medical | $139.47 | 2024 | Generator |
| Abbvie INC. | $62.18 | 2024-2025 | |
| Tersera Therapeutics LLC | $43.64 | 2023 | Prialt |
| Mml US, INC. | $21.14 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Amir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.